Metric Analysis: Guardant Health Inc (GH)’s Key Ratios in the Limelight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Guardant Health Inc (NASDAQ: GH) closed at $25.58 down -1.35% from its previous closing price of $25.93. In other words, the price has decreased by -$1.35 from its previous closing price. On the day, 2.5 million shares were traded. GH stock price reached its highest trading level at $26.32 during the session, while it also had its lowest trading level at $25.275.

Ratios:

For a deeper understanding of Guardant Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.07 and its Current Ratio is at 6.40.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 04 ’24 when Joyce Meghan V. sold 100 shares for $27.87 per share. The transaction valued at 2,787 led to the insider holds 4,621 shares of the business.

Kalia Kumud bought 2,187 shares of GH for $38,963 on Mar 18 ’24. The Chief Information Officer now owns 12,722 shares after completing the transaction at $17.82 per share. On Mar 04 ’24, another insider, Joyce Meghan V., who serves as the Director of the company, sold 100 shares for $19.05 each. As a result, the insider received 1,905 and left with 4,521 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 3146902784 and an Enterprise Value of 3501860608. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.89. Its current Enterprise Value per Revenue stands at 5.439 whereas that against EBITDA is -9.162.

Stock Price History:

Over the past 52 weeks, GH has reached a high of $41.06, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is -14.97%, while the 200-Day Moving Average is calculated to be 3.86%.

Shares Statistics:

For the past three months, GH has traded an average of 2.15M shares per day and 2344800 over the past ten days. A total of 121.63M shares are outstanding, with a floating share count of 116.88M. Insiders hold about 4.99% of the company’s shares, while institutions hold 95.29% stake in the company. Shares short for GH as of 1723680000 were 9387842 with a Short Ratio of 4.36, compared to 1721001600 on 6842675. Therefore, it implies a Short% of Shares Outstanding of 9387842 and a Short% of Float of 7.95.

Most Popular